Giant Papillary Conjunctivitis Latest Advances
Find the Latest Research About Giant Papillary Conjunctivitis
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4486 publications
Comparative Efficacy and Safety of Topical Bepotastine Besilate 1.5% Versus Sodium Cromoglycate 4% in Chronic Allergic Conjunctivitis: A Prospective Study.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: June 10, 2026
Allergic eye disease in clinical practice: essential updates for eye care professionals.
Journal: Clinical & experimental optometry
Published: June 04, 2026
Development and characterization of olopatadine and verbascoside-loaded thermoresponsive in situ gels for ocular drug delivery: a factorial design approach for allergic conjunctivitis.
Journal: Drug development and industrial pharmacy
Published: May 29, 2026
Immune Privilege of the Eye: A Delicate Balance Between Clarity and Chaos.
Journal: Ocular immunology and inflammation
Published: May 21, 2026
Effects of Inhalation of Hydrogen Gas on Allergic Conjunctivitis Model Mice.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: May 08, 2026
Ocular manifestations of allergies - options for self-treatment.
Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Published: May 04, 2026
Consensus Review: Predicting Recurrence in Chronic Rhinosinusitis With Nasal Polyps: Multidisciplinary Insights From the RELAPSE Project.
Journal: Journal of investigational allergology & clinical immunology
Published: April 29, 2026
Phenotype of Tear Leukocytes in Seasonal Ocular Allergy and Their Potential Impacts on Ocular Surface Inflammation.
Journal: Ocular immunology and inflammation
Published: April 14, 2026
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution in Children and Adolescents: An 8-Week Phase 3 Study.
Journal: Journal of investigational allergology & clinical immunology
Published: March 27, 2026
Last Updated: 06/30/2026